Literature DB >> 16805831

Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells.

Alessandra Caruso1, Marta Motolese, Luisa Iacovelli, Filippo Caraci, Agata Copani, Ferdinando Nicoletti, Georg C Terstappen, Giovanni Gaviraghi, Andrea Caricasole.   

Abstract

We examined the effect of the three human isoforms of apolipoprotein E (ApoE2, ApoE3, and ApoE4) on the canonical Wnt signaling pathway in undifferentiated PC12 cells. Addition of recombinant ApoE4 reduced Wingless-Int7a-stimulated gene expression at concentrations of 80 and 500 nm. Recombinant ApoE2 and ApoE3 were virtually inactive. Recombinant ApoE4 also inhibited Wnt signaling when combined with very low density lipoproteins (VLDLs) or in cells over-expressing the low density lipoprotein receptor-related protein, LRP6. In contrast, the enforced expression of LRP5 unmasked an inhibition by ApoE2 and ApoE3, which, however, were less effective than ApoE4 in inhibiting Wnt signaling. We also transfected PC12 cells with constructs encoding for the three human ApoE isoforms to examine whether endogenously expressed ApoE isoforms could modulate the Wnt pathway. Under these conditions, all three ApoE isoforms were able to inhibit Wnt signaling, although ApoE4 showed the greatest efficacy. Only the conditioned medium collected from cultures transfected with ApoE4 induced a significant inhibition of Wnt7a-stimulated gene expression, confirming that ApoE4 has an extracellular action that is not shared by the other ApoE isoforms. We conclude that ApoE4 behaves as an inhibitor of the canonical Wnt pathway in a context-independent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805831     DOI: 10.1111/j.1471-4159.2006.03867.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  35 in total

1.  The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions.

Authors:  Paul Denny; Fred K Hagen; Markus Hardt; Lujian Liao; Weihong Yan; Martha Arellanno; Sara Bassilian; Gurrinder S Bedi; Pinmannee Boontheung; Daniel Cociorva; Claire M Delahunty; Trish Denny; Jason Dunsmore; Kym F Faull; Joyce Gilligan; Mireya Gonzalez-Begne; Frédéric Halgand; Steven C Hall; Xuemei Han; Bradley Henson; Johannes Hewel; Shen Hu; Sherry Jeffrey; Jiang Jiang; Joseph A Loo; Rachel R Ogorzalek Loo; Daniel Malamud; James E Melvin; Olga Miroshnychenko; Mahvash Navazesh; Richard Niles; Sung Kyu Park; Akraporn Prakobphol; Prasanna Ramachandran; Megan Richert; Sarah Robinson; Melissa Sondej; Puneet Souda; Mark A Sullivan; Jona Takashima; Shawn Than; Jianghua Wang; Julian P Whitelegge; H Ewa Witkowska; Lawrence Wolinsky; Yongming Xie; Tao Xu; Weixia Yu; Jimmy Ytterberg; David T Wong; John R Yates; Susan J Fisher
Journal:  J Proteome Res       Date:  2008-03-25       Impact factor: 4.466

Review 2.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

3.  SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.

Authors:  Qiao-Yang Sun; Ling-Wen Ding; Jin-Fen Xiao; Wenwen Chien; Su-Lin Lim; Norimichi Hattori; Lee Goodglick; David Chia; Vei Mah; Mohammad Alavi; Sara R Kim; Ngan B Doan; Jonathan W Said; Xin-Yi Loh; Liang Xu; Li-Zhen Liu; Henry Yang; Takahide Hayano; Shuo Shi; Dong Xie; De-Chen Lin; H Phillip Koeffler
Journal:  J Pathol       Date:  2014-12-18       Impact factor: 7.996

4.  Wnt transmembrane signaling and long-term spatial memory.

Authors:  Nino Tabatadze; Caroline Tomas; Rhona McGonigal; Brian Lin; Andrew Schook; Aryeh Routtenberg
Journal:  Hippocampus       Date:  2011-12-19       Impact factor: 3.899

Review 5.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

6.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

Review 7.  Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

Authors:  Scott A Small; Karen Duff
Journal:  Neuron       Date:  2008-11-26       Impact factor: 17.173

8.  Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.

Authors:  Octavio Mercado-Gómez; Karla Hernández-Fonseca; Alexa Villavicencio-Queijeiro; Lourdes Massieu; Jesús Chimal-Monroy; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

Review 9.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

10.  Notch signaling in cardiovascular disease and calcification.

Authors:  Gabriel Rusanescu; Ralph Weissleder; Elena Aikawa
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.